Creative Planning - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.

Quarter-by-quarter ownership
Creative Planning ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$1,933,641
-3.0%
124,993
-1.5%
0.00%0.0%
Q2 2023$1,994,291
+22.0%
126,944
+28.0%
0.00%
+50.0%
Q1 2023$1,634,418
+58.6%
99,176
+50.1%
0.00%0.0%
Q4 2022$1,030,536
+18.0%
66,060
-1.9%
0.00%0.0%
Q3 2022$873,000
+47.0%
67,340
+59.3%
0.00%
+100.0%
Q2 2022$594,000
+13.6%
42,283
+15.8%
0.00%0.0%
Q1 2022$523,000
+22.8%
36,504
+16.9%
0.00%0.0%
Q4 2021$426,000
-26.3%
31,221
-11.5%
0.00%0.0%
Q3 2021$578,000
+6.1%
35,292
+8.9%
0.00%0.0%
Q2 2021$545,000
-31.8%
32,399
-26.0%
0.00%
-50.0%
Q1 2021$799,000
+25.6%
43,765
+25.2%
0.00%
+100.0%
Q4 2020$636,000
-33.2%
34,959
-34.5%
0.00%
-50.0%
Q3 2020$952,000
+17.8%
53,384
+18.5%
0.00%0.0%
Q2 2020$808,000
+9.2%
45,037
-7.6%
0.00%
-33.3%
Q1 2020$740,000
-23.3%
48,724
-0.4%
0.00%0.0%
Q4 2019$965,000
+8.3%
48,904
-5.6%
0.00%0.0%
Q3 2019$891,000
-2.3%
51,823
+0.6%
0.00%0.0%
Q2 2019$912,000
+18.3%
51,509
+36.2%
0.00%0.0%
Q1 2019$771,00037,8300.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders